Related Experiment Videos

Proton pump inhibitors and Raynaud's phenomenon: is there a link?

Charles Khouri^1,2,3, Bruno Revol^1,3, Jean-Luc Cracowski^2,3

¹Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.

British Journal of Clinical Pharmacology

|July 14, 2018

Abstract

No abstract available in PubMed .

Keywords:

Raynaud's phenomenon drug safety proton pump inhibitors

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Redefining Regulatory Proof: The End of the Two-Trial Paradigm.

Fundamental & clinical pharmacology·2026

Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.

ERJ open research·2026

Cyclin-dependent kinase inhibitors and kidney injury: Analysis of the French pharmacovigilance database.

Therapie·2026

Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer.

Nature·2026

Comparison of the effect of donepezil and a combination of donepezil and mefloquine (THN201) on cognition during a scopolamine challenge in healthy participants.

Experimental and clinical psychopharmacology·2026

Endothelial cell senescence and mitochondrial dysfunction in vascular ageing.

Ageing research reviews·2026

See all related articles